quinpirole has been researched along with Parkinsonian Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Blass, BE; Bohmann, J; Chen, PJ; Daadi, ES; Daadi, EW; Daadi, MM; Kim, J; Oh, T; Roy-Choudhury, G | 1 |
| Chen, D; Guo, M; He, F; Jia, Q; Li, M; Li, Y; Sun, S; Sun, Y; Wang, M; Wang, X; Xiang, T; Yao, X; Zhang, X | 1 |
| Abbaszadeh, M; Andreoli, L; Cao, X; Cenci, MA | 1 |
| Johnson, NW; Özkan, M; Sehirli, US; Stanford, IM; Woodhall, GL | 1 |
| Bastioli, G; Calabresi, P; Costa, C; Di Filippo, M; Durante, V; Mancini, A; Mazzocchetti, P; Mechelli, A; Morari, M; Novello, S; Tozzi, A | 1 |
| Ganguly, A; Lee, D; Schultz, BJ; Wiemerslage, L | 1 |
| Barraud, Q; Bezard, E; Ghorayeb, I; Hyacinthe, C; Tison, F | 1 |
| Cruz, AV; Delaville, C; Dupre, KB; Eyring, KW; Gerber, CM; McCoy, AJ; Walters, JR | 1 |
| Ballion, B; Chetrit, J; Frenois, F; Gonon, F; Murer, MG; Zold, CL | 1 |
| Cohen, BN; Gardner, PD; Grady, SR; Just, H; Lester, HA; McClure-Begley, T; Salminen, O; Tapper, AR; Whiteaker, P; Zhao-Shea, R | 1 |
| El Massioui, N; Faure, A; Leblanc-Veyrac, P | 1 |
| Baufreton, J; Bezard, E; Bioulac, B; Goillandeau, M; Martinez, A; Miguelez, C; Morin, S | 1 |
| Bernardi, G; Calabresi, P; Costa, C; Goldberg, MS; Haburcak, M; Kitada, T; Martella, G; Martins, A; Pisani, A; Pothos, EN; Roth, BL; Shen, J; Tong, Y; Tscherter, A; Vortherms, TA | 1 |
| Bisogno, T; Brotchie, JM; Crossman, AR; Di Marzo, V; Hill, MP | 1 |
| Carta, A; Fenu, S; Morelli, M | 1 |
| Eoh, W; Hong, SC; Kim, JH; Kim, JS; Lee, JI; Lee, WY; Nam, DH; Park, K; Shin, HJ | 1 |
16 other study(ies) available for quinpirole and Parkinsonian Disorders
| Article | Year |
|---|---|
Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's disease.
Topics: Animals; Antiparkinson Agents; Callithrix; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; HEK293 Cells; Humans; Levodopa; Ligands; Parkinsonian Disorders; Primates; Protein Structure, Secondary; Quinpirole; Receptors, Dopamine D3 | 2022 |
Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Locomotion; Male; Motor Activity; Parkinson Disease; Parkinsonian Disorders; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2021 |
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzimidazoles; Dyskinesia, Drug-Induced; Dystonia; Mice; Movement; Oxidopamine; Parkinsonian Disorders; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2021 |
Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Benzazepines; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Male; Motor Cortex; Neurons; Parkinsonian Disorders; Prazosin; Quinpirole; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2017 |
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.
Topics: Animals; Corpus Striatum; Dopamine Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Parkinsonian Disorders; Quinpirole; Receptors, Dopamine D2; Synaptic Transmission | 2018 |
Selective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary culture.
Topics: 1-Methyl-4-phenylpyridinium; Action Potentials; Animals; Animals, Genetically Modified; Bromocriptine; Cholinergic Neurons; Dopamine Agonists; Dopaminergic Neurons; Drosophila melanogaster; Drosophila Proteins; Female; GABAergic Neurons; Male; Nerve Degeneration; Parkinsonian Disorders; Primary Cell Culture; Quinpirole; Receptors, Dopamine D2 | 2013 |
D1 receptor agonist improves sleep-wake parameters in experimental parkinsonism.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Electrocardiography; Electroencephalography; Electromyography; Female; Levodopa; Macaca fascicularis; Macaca mulatta; Parkinsonian Disorders; Quinpirole; Sleep; Sleep Disorders, Circadian Rhythm; Telemetry; Time Factors; Wakefulness | 2014 |
Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzazepines; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Gamma Rhythm; Levodopa; Male; Motor Activity; Motor Cortex; Neurons; Oxidopamine; Parkinsonian Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 2016 |
D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Levodopa; Male; Neurons; Oxidopamine; Parkinsonian Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2009 |
Dopamine D2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive {alpha}4 nicotinic receptors via a cholinergic-dependent mechanism.
Topics: Acetylcholine; Amino Acid Substitution; Animals; Catalepsy; Cholinergic Fibers; Dopamine Agonists; Epilepsy, Generalized; Female; Interneurons; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle Rigidity; Mutagenesis, Site-Directed; Parkinsonian Disorders; Quinpirole; Receptors, Dopamine D2; Receptors, Nicotinic; Recombinant Proteins; Tremor | 2010 |
Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Conditioning, Operant; Corpus Striatum; Dopamine; Dopamine Agonists; Extinction, Psychological; Habits; Male; Oxidopamine; Parkinsonian Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reward | 2010 |
Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease.
Topics: Animals; Calcium; Disease Models, Animal; Dopamine; Dopamine Agonists; GABAergic Neurons; Globus Pallidus; Inhibitory Postsynaptic Potentials; Miniature Postsynaptic Potentials; Optogenetics; Parkinsonian Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Strontium | 2012 |
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Behavior, Animal; Blotting, Southern; Blotting, Western; Cell Count; Cerebral Cortex; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Electric Stimulation; Electrochemistry; Excitatory Postsynaptic Potentials; Germ-Line Mutation; Humans; Hypokinesia; Immunohistochemistry; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Oncogene Proteins; Parkinsonian Disorders; Protein Deglycase DJ-1; Quinpirole; Radioligand Assay; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.
Topics: Animals; Arachidonic Acids; Benzazepines; Cannabinoid Receptor Modulators; Cannabinoids; Dopamine Agonists; Endocannabinoids; Globus Pallidus; Glycerides; Humans; Male; Motor Activity; Parkinsonian Disorders; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Reserpine; Rimonabant; Substantia Nigra; Tissue Distribution | 2000 |
Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dopamine Agonists; Down-Regulation; Drug Interactions; Drug Tolerance; Dynorphins; Enkephalins; Gene Expression; Glutamate Decarboxylase; Isoenzymes; Levodopa; Neostriatum; Neurons; Oxidopamine; Parkinsonian Disorders; Quinpirole; Rats; RNA, Messenger; Sympatholytics; Up-Regulation | 2001 |
Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine.
Topics: Animals; Apomorphine; Dopamine Agonists; Male; MPTP Poisoning; Oxidopamine; Parkinsonian Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Substantia Nigra | 2001 |